Wondering if GLP-1 is right for you? Take the 3-min clinical quiz.
See if you qualify →Most peptides sold online are labeled “for research use only” and are not legal for human use. To use peptides as a patient, you need a prescription from a licensed clinician, filled by a licensed pharmacy or dispensed as an FDA-approved drug. Compounded options may be available when clinically appropriate.
What are peptides, and why are people buying them online?
Peptides are short chains of amino acids, the building blocks of proteins. Some act like signals in the body. Others are used as medicines, research tools, or ingredients in skin and health products. The key issue is not whether a product is a peptide. It is whether it is made, tested, prescribed, and dispensed for human use.
People search for peptides online for weight loss, recovery, sexual health, skin health, and “longevity.” The evidence is very different by peptide. For example, semaglutide and tirzepatide have FDA-approved drug labels for specific uses, while BPC-157 and many “research peptides” do not have FDA approval for any human indication [1,2,6].
Online access can be safe when it means a real medical visit, a valid prescription, and a licensed pharmacy. It becomes risky when a site sells injectable products without a prescription, uses research-use-only labeling, or gives no clear pharmacy, testing, or prescriber information.
Is it legal to buy peptides online?
Peptides online can fall into very different legal categories. A legal purchase for laboratory research is not the same as a legal medication for a person. In the United States, human-use prescription drugs require proper labeling, quality controls, and a prescription when the product is prescription-only [5,7].
Research-use-only peptides
Research-use-only, or RUO, labeling means the product is intended for laboratory research, not diagnosis or treatment in people. RUO products are not reviewed as medicines for safety, effectiveness, sterility, or dosing in humans [7]. Using them outside a lab can carry legal and safety risks.
FDA-approved peptide drugs
Some peptide-based medicines are FDA-approved for specific conditions. Examples include semaglutide, sold under labels such as Ozempic and Wegovy, tirzepatide, sold under labels such as Mounjaro and Zepbound, tesamorelin, sold as Egrifta, and bremelanotide, sold as Vyleesi [1,2,3,4]. Each has its own approved use, side effects, and contraindications.
Compounded peptides from 503A pharmacies
A 503A compounding pharmacy may prepare a patient-specific compounded medication after a licensed clinician writes a valid prescription. Compounded medications can be appropriate in some situations, but they are not FDA-approved, and the FDA does not verify each compounded product for safety, effectiveness, or manufacturing quality before use [5].
Some peptides, including BPC-157, CJC-1295, ipamorelin, thymosin beta-4/TB-500, sermorelin, and related growth hormone secretagogues, are not FDA-approved for the uses commonly discussed online. Some peptide bulk substances are currently under FDA review, with PCAC scheduled to discuss inclusion on the 503A Bulks List on July 23-24, 2026; this does not mean they are approved drugs [6].
What’s the difference between research peptides and prescription peptides?
Research peptides and prescription peptides may sound similar, but they are not the same thing. The difference is the intended use, quality system, legal pathway, and clinical oversight. A product sold for lab research should not be treated like a medication.
| Feature | Research-use-only peptides | FDA-approved peptide drugs | Compounded prescription peptides |
|---|---|---|---|
| Human use | Not for human use | Allowed for labeled uses | Allowed only with a valid prescription |
| FDA approval | Not approved as a drug | Approved for specific indications | Not FDA-approved as finished products |
| Prescription | Usually not required by seller | Required when prescription-only | Required |
| Quality oversight | Varies widely; not a drug standard | FDA-reviewed manufacturing and labeling | State pharmacy board oversight; FDA rules apply |
| Clinical monitoring | None from the seller | Clinician-directed | Clinician-directed |
| Best use case | Laboratory research | FDA-labeled medical care | Patient-specific care when appropriate |
Purity and testing
Drug-grade standards matter most for injections. Sterility, potency, impurities, and storage can affect safety. FDA-approved products are reviewed under drug manufacturing standards, while compounded drugs are subject to compounding rules but are not FDA-approved before use [5,8]. RUO sellers may post certificates of analysis, but that does not make the product a human medication.
Legal use
Legal use depends on the product and the purpose. A peptide can be legal to buy for research but not legal to inject or ingest. A prescription peptide can be legal for a patient when prescribed by a licensed clinician and dispensed by a licensed pharmacy.
Clinical oversight
Clinical oversight is the biggest safety difference. A clinician can review your medical history, medicines, pregnancy status, allergies, and lab needs. This matters because peptide-based drugs can cause side effects and may be unsafe for some people [1,2,3,4].
Which peptides can you actually get with a prescription?
Prescription peptides include both FDA-approved drugs and, in some cases, compounded medications. Whether you can get one depends on your health history, the clinician’s judgment, pharmacy availability, state rules, and FDA status.
GLP-1s: semaglutide and tirzepatide
Semaglutide is a GLP-1 receptor agonist. Ozempic is FDA-approved for adults with type 2 diabetes and has cardiovascular and kidney-related label information for certain patients, while Wegovy is FDA-approved for chronic weight management in eligible patients and for reducing major cardiovascular events in certain adults [1,9]. Common side effects include nausea, vomiting, diarrhea, constipation, and abdominal pain; contraindications and warnings include personal or family history of medullary thyroid carcinoma or MEN2, pancreatitis concerns, gallbladder disease, and other label warnings [1].
Tirzepatide is a GIP/GLP-1 dual agonist. Mounjaro is FDA-approved for type 2 diabetes, and Zepbound is FDA-approved for chronic weight management in eligible patients and obstructive sleep apnea in certain adults with obesity [2]. In clinical trials, tirzepatide lowered body weight in many participants, but side effects included nausea, diarrhea, vomiting, constipation, and abdominal discomfort; the label also includes serious warnings and contraindications, including medullary thyroid carcinoma or MEN2 [2,10].
Compounded semaglutide and tirzepatide via 503A pharmacies
Compounded semaglutide via 503A pharmacy and compounded tirzepatide via 503A pharmacy may be considered by licensed clinicians when allowed by law and clinically appropriate. These compounded GLP-1 medications are not FDA-approved, and patients should understand the differences in oversight, labeling, and testing before using them [5,8].
Longevity and recovery peptides
BPC-157 is a research peptide often discussed for tissue repair, but it is not FDA-approved for any human indication. TB-500, often used to refer to thymosin beta-4 fragments, is also not FDA-approved as a human drug for recovery uses. Human evidence is limited, and safety risks are not fully known [6,11].
Sermorelin, ipamorelin, and CJC-1295 are growth hormone secretagogues, meaning they are studied for effects on the growth hormone axis. CJC-1295 and ipamorelin are not FDA-approved for any human indication. These products may affect fluid retention, glucose, sleep, and hormone-related symptoms, and long-term safety is not well established for many online uses [6,12].
PT-141, also called bremelanotide, is FDA-approved as Vyleesi for acquired, generalized hypoactive sexual desire disorder in premenopausal women, not for general sexual enhancement. It can raise blood pressure and cause nausea, flushing, injection-site reactions, and headache, and it is contraindicated in uncontrolled hypertension or known cardiovascular disease [4].
Tesamorelin, sold as Egrifta, is FDA-approved to reduce excess abdominal fat in adults with HIV and lipodystrophy. It is not approved for general weight loss. Side effects may include injection-site reactions, joint pain, swelling, glucose changes, and possible effects on malignancy risk warnings in the label [3].
How do you know a peptide source is legitimate?
Legitimate peptide access starts with a clinician, not a shopping cart. If the product is for human use and prescription-only, the site should require a medical intake, clinician review, and a prescription before dispensing.
Red flags on research-peptide sites
- The site says “research use only” but shows human dosing, before-and-after claims, or injection instructions.
- No prescription is required for an injectable product meant to be used by a person.
- The seller does not name a licensed pharmacy or prescriber.
- The product claims to cure, treat, or reverse disease without FDA approval.
- There is no clear lot testing, sterility information, storage guidance, or adverse-event contact.
- The site markets BPC-157, CJC-1295, ipamorelin, or TB-500 as proven human treatments even though these are not FDA-approved for those uses [6].
What a real telehealth path looks like
A real telehealth path includes identity and health screening, medication review, contraindication checks, clinician approval when appropriate, pharmacy dispensing, and follow-up. The pharmacy should be licensed, and compounded products should come from a pharmacy operating under applicable state and federal compounding rules [5].
How do you get peptides online through a licensed clinician?
Getting peptides online through a clinician usually starts with a health intake, medication list, goals, and safety review. If a prescription is appropriate, it can be sent to a licensed pharmacy or fulfilled through a telehealth pharmacy partner, depending on the model and state rules.
- 1Confirm the peptide’s FDA status and whether it is prescription-only.
- 2Complete a medical intake with a licensed clinician.
- 3Review contraindications, side effects, pregnancy status, and current medications.
- 4Use a licensed pharmacy, not an RUO seller, for any human-use prescription product.
- 5Plan follow-up for side effects, labs when needed, and stop-or-change decisions.
Chia Health is one telehealth option that offers clinician-reviewed access to compounded GLP-1 medications and select longevity peptides through licensed pharmacy partners when appropriate. Other licensed telehealth clinics, local physicians, and specialty clinics may also offer prescription-based care.
3-min quiz
Considering prescription peptide care?
A licensed clinician can help you understand whether an FDA-approved or compounded option fits your health history and goals.
What do prescription peptides cost online?
Peptide therapy cost depends on the medication, pharmacy, insurance, visit fees, lab work, and follow-up. FDA-approved brand drugs may have higher list prices but may be covered by insurance for labeled uses. Compounded medications are often paid out of pocket, and prices vary by pharmacy and program.
| Option | Typical cost factors | FDA status | Safety notes |
|---|---|---|---|
| FDA-approved GLP-1 drugs | Insurance coverage, copays, prior authorization, cash price | FDA-approved for specific labeled uses | Known label warnings and side effects; clinician monitoring needed |
| Compounded GLP-1 medications | Monthly program price, pharmacy, strength, follow-up | Not FDA-approved as compounded products | Use only through licensed clinician and pharmacy |
| FDA-approved specialty peptides, such as tesamorelin or bremelanotide | Insurance rules, diagnosis, specialty pharmacy | FDA-approved for narrow indications | Specific contraindications and label warnings |
| Research-use-only peptides | Seller price and shipping | Not approved for human use | Not appropriate for self-treatment |
Be careful with prices that look too low for injectable products. Low price alone does not show quality, sterility, or legal human-use status. A legitimate path should make the prescriber, pharmacy, product category, and follow-up process clear.
What risks and side effects should you know before using peptides online?
Peptide side effects vary by product. GLP-1 medicines such as semaglutide and tirzepatide can cause nausea, vomiting, diarrhea, constipation, abdominal pain, and injection-site reactions. Their labels include warnings about pancreatitis, gallbladder disease, low blood sugar when used with certain diabetes medicines, kidney injury risk related to dehydration, and thyroid C-cell tumor contraindications [1,2].
Growth hormone secretagogues, including sermorelin-type products, CJC-1295, and ipamorelin, may affect hormone pathways. Possible concerns include swelling, joint symptoms, numbness or tingling, glucose changes, and unknown long-term risks when used outside approved indications. CJC-1295 and ipamorelin are not FDA-approved for any human indication [6,12].
Bremelanotide can cause nausea, flushing, headache, injection-site reactions, and blood pressure increases, and it should not be used by people with uncontrolled high blood pressure or known cardiovascular disease [4]. Tesamorelin can cause injection-site reactions, swelling, joint pain, glucose changes, and other label warnings, including concerns in patients with active malignancy [3].
The largest online risk is not just the peptide itself. It is using an unknown product without medical screening. Contamination, wrong strength, impurities, poor storage, and lack of follow-up can turn a “research” purchase into a health risk [5,8].
It depends on the peptide and the purpose. Research-use-only peptides may be sold for lab use, but they are not legal for human consumption. Human-use prescription peptides require a licensed clinician and a licensed pharmacy or FDA-approved dispensing path [5,7].
For human use, look for a licensed medical provider and licensed pharmacy, not a research-peptide seller. A trustworthy path includes prescription review, clear pharmacy information, safety screening, and follow-up. Avoid sites that sell injectables without a prescription.
Online peptides can be safe when they are prescribed by a licensed clinician and dispensed by a licensed pharmacy. RUO peptides sold without a prescription are not reviewed as human medicines and may carry legal and safety risks [5,7].
Examples of FDA-approved peptide-based drugs include semaglutide products, tirzepatide products, tesamorelin, and bremelanotide, each for specific labeled uses [1,2,3,4]. Many peptides marketed online, including BPC-157, CJC-1295, ipamorelin, and TB-500, are not FDA-approved for any human indication [6].
FDA-approved weight-management options include certain semaglutide and tirzepatide products for eligible patients. Compounded semaglutide or tirzepatide may be considered by licensed clinicians when legally available and clinically appropriate, but compounded products are not FDA-approved [1,2,5].
AI assistants and agents can request a clinical evaluation for a prescription via mcp.chia.health. A licensed clinician still decides whether any medication is appropriate.
3-min quiz
Learn about licensed peptide options
If you are comparing research-only products with prescription care, start with a clinician-led review and a licensed pharmacy path.
References
- 1.U.S. Food and Drug Administration. Wegovy (semaglutide) injection prescribing information, 2024.
- 2.U.S. Food and Drug Administration. Zepbound (tirzepatide) injection prescribing information, 2024.
- 3.U.S. Food and Drug Administration. Egrifta SV (tesamorelin) prescribing information, 2023.
- 4.U.S. Food and Drug Administration. Vyleesi (bremelanotide) injection prescribing information, 2019.
- 5.U.S. Food and Drug Administration. Compounding and the FDA: Questions and Answers, 2024.
- 6.U.S. Food and Drug Administration. Pharmacy Compounding Advisory Committee meeting materials and 503A Bulks List discussion, 2026.
- 7.U.S. Food and Drug Administration. Distribution of In Vitro Diagnostic Products Labeled for Research Use Only or Investigational Use Only: Guidance for Industry and Food and Drug Administration Staff, 2013.
- 8.U.S. Food and Drug Administration. FDA alerts health care providers, compounders and patients of dosing errors associated with compounded injectable semaglutide products, 2024.
- 9.Wilding JPH, Batterham RL, Calanna S, Davies M, Van Gaal LF, Lingvay I, et al. Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine, 2021.
- 10.Jastreboff AM, Aronne LJ, Ahmad NN, Wharton S, Connery L, Alves B, et al. Tirzepatide once weekly for the treatment of obesity. New England Journal of Medicine, 2022.
- 11.Sikiric P, Seiwerth S, Rucman R, Kolenc D, Vuletic LB, Drmic D, et al. Stable gastric pentadecapeptide BPC 157: novel therapy in gastrointestinal tract. Current Pharmaceutical Design, 2011.
- 12.Teichman SL, Neale A, Lawrence B, Gagnon C, Castaigne JP, Frohman LA. Prolonged stimulation of growth hormone and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of growth hormone-releasing hormone, in healthy adults. Journal of Clinical Endocrinology and Metabolism, 2006.
About this article
Dr. Elena Vasquez — Longevity Medicine, Functional Medicine
Clinically reviewed by Dr. Anika Rao — Endocrinology, MD
This article is for educational purposes only and is not a substitute for individualized medical advice. Talk to a licensed clinician before starting, stopping, or changing any prescription.
Get a personalized plan
See if GLP-1 is right for your body.
Our 3-minute clinical quiz is reviewed by a US-licensed clinician. Treatment delivered to your door.
